Squarex Pharmaceutical Corporation (SQRX)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	n/a
Revenue (ttm)	n/a
Net Income (ttm)	-635,099
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About SQRX

Squarex Pharmaceutical is a late-clinical-stage pharmaceutical company developing a drug that is intended to improve immune function to reduce severity and incidence of infectious disease with an initial focus on oral herpes. Our drug SQX770 has completed a Phase 1 and a Phase 2 placebo-controlled clinical trial and showed a statistically significant effect in non-primary endpoints in both trials of delaying time to next herpes labialis or oral herpes (cold sore) outbreak and reducing the number of outbreaks of cold sores (herpes labialis) afte...

• Industry: Health Care
• Sector: Pharmaceuticals
• Founded: 2012
• Employees: 1
• Stock Exchange: NASDAQ
• Ticker Symbol: SQRX